Neoadjuvant Chemotherapy for Osteosarcoma of the Extremities with Metastases at Presentation: Recent Experience at the Rizzoli Institute in 57 Patients Treated with Cisplatin, Doxorubicin, and a High Dose of Methotrexate and Ifosfamide.|Citation only
Neoadjuvant Chemotherapy for Osteosarcoma of the Extremities with Metastases at Presentation: Recent Experience at the Rizzoli Institute in 57 Patients Treated with Cisplatin, Doxorubicin, and a High Dose of Methotrexate and Ifosfamide.|Citation only